Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin America – PRNewswire

SO PAULO, Brazil and BOSTON, Aug. 24, 2021 /PRNewswire/ -- Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Homologous recombination deficiency) analytics solution in Latin America. HRD is a complex biomarker, important for PARP inhibitors, that helps identify whether cancer patients may respond better to specific treatments, and its use could ultimately lead to personalized therapies that benefit the individual patient.

Renowned in Brazil and abroad, Dasa serves more than 20 million patients per year including approximately 10% of the Brazilian population - through its more than 250,000 medical partners comprised of more than 59 diagnostic medicine brands and hospitals. With the help of the knowledge pooling SOPHiA DDMTM platform, Dasa has drawn further insights upon the many complex molecular datasets that they analyze for the benefit of their patients.

Today's announcement further builds on the partnership that began between the two companies in 2016, when Dasa chose SOPHiA GENETICS to build the original workflow for its genomics lab. This partnership further evolved when Dasa implemented SOPHiA DDMTMRadiomics and Trial Match solutions in 2020 to create the first multimodal approach in the region.For half a decade, the two companies have pioneered new ways to enable scalability and high output screening on complex assays, shortening the path from research to consumer applications and more.

"SOPHiA GENETICS' decentralized approach gives us automated and reproducible results in-house. Their expert bioinformatics team got us up and running on our own, helping us save considerable time, gain efficiency, and offer a more affordable solution for patients," said Gustavo Riedel, Business Director for Genomics and LATAM Clinical Research at Dasa.

"Dasa initially wanted to be able to track the entire diagnostic journey for their cancer patients. With such a large regional network, this is a task that's not unlike navigating an ocean of data through a hurricane. Through our past collaborations and now the addition of our decentralized HRD solution - SOPHiA GENETICS is able to act as the lighthouse that guides Dasa through the storm as they make new discoveries, helping both short and long-term patient care," said Jurgi Camblong, Co-founder and CEO of SOPHiA GENETICS.

To learn more about how SOPHiA GENETICS data-driven insights are improving diagnosis, treatment and drug development for patients and the larger medical community, visit sophiagenetics.com.

About SOPHiA GENETICS:SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

More info:SOPHiAGENETICS.COM; follow@SOPHiAGENETICSon Twitter

About Dasa:Dasa is the largest integrated healthcare network in Brazil, serving more than 20 million people a year, with high technology, intuitive experience and an attitude ahead of time. With more than 40 thousand employees and 250 thousand partner doctors, Dasa is the healthcare solution that people want and that the world needs, being present at every stage of care.

Dasa believes that in order to take care, it is always necessary to take care fully. Therefore, it looks at health management in a preventive, predictive and personalized way. It integrates diagnostic medicine, hospitals, genomics, oncology, care coordination, emergency care, telemedicine, clinical research and science. In all, it has 15 reference hospitals (considering its own network, inorganic growth and deals that are still under regulatory approval), and more than 59 brands including diagnostic medicine and hospitals, distributed in more than 900 units in Brazil.

Dasa guarantees agile, uncomplicated and friction-free navigation of the health journey, for both patients and physicians through its management platform, Nav. In addition, it offers integrated and innovative corporate health solutions through Dasa Empresas. We are Dasa and we are for life. For more information, access: http://www.dasa.com.br.

Contact: [emailprotected]

SOURCE SOPHiA GENETICS

Continue reading here:
Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin America - PRNewswire

Study Finds Genetics Rather Than Environment Are Source of THC Levels in Hemp – AgNet West

A recent study from Cornell University has found no link between increases in the THC content in hemp with environmental or biological stresses. Guidelines from USDAs Agricultural Marketing Service note that the threshold for THC content is 0.3 percent. USDA has recently raised what it considers to be a negligent crop from THC levels of .5 percent to one percent, reducing some risk for growers. Senior author of the study and professor in the horticulture section of the School of Integrative Plant Science in the College of Agriculture and Life Sciences, Larry Smart said that their findings should help to provide some comfort regarding the CBD to THC ratio in hemp.

Theresearch projectincluded control plots and five stress treatments that were applied to three genetically unrelated high-CBD hemp cultivars. The stress treatments included flood conditions, physical wounding, exposure to a particular plant growth regulator, powdery mildew, and herbicide. Over the four-week maturation period, tests showed that THC content increased proportionally for all of the different stress treatments imposed on the different cultivars. The study provides support for genetics being the determining factor for THC content in hemp plants rather than environmental stresses. Further research and breeding will be needed to better determine the appropriate genetics for achieving a high CDB content with acceptable levels of THC.

Listen to the radio report below.

Related

Read more:
Study Finds Genetics Rather Than Environment Are Source of THC Levels in Hemp - AgNet West

Genetic Analyses Trace How Mutations Accumulate in Cells of the Human Body Over Time – GenomeWeb

NEW YORK A suite of new studies has examined how one cell develops into all the tissues of the human body by tracing and investigating the mutations they acquire over time.

As cells divide, they acquire mutations that are then passed on to their daughter cells. The resulting patterns of mutations can be used to trace back a cell's family tree, possibly all the way to the first cell. In four new studies appearing Wednesday in Nature, teams of researchers from across the world used this approach to study the earliest stages of human development as well as the later accumulation of somatic mutations, including ones linked to cancer.

"Exploring the human body via the mutations cells acquire as we age is as close as we can get to studying human biology in vivo," Luiza Moore, a researcher at the Wellcome Sanger Institute and first author of one of the studies, said in a statement. "Our life history can be found in the history of our cells, but these studies show that this history is more complex than we might have assumed."

Tracing these mutations back in time revealed differences in mutation rates very early in embryonic development. Researchers led by the Sanger Institute's Michael Stratton uncovered a pattern of mutations that indicated a high initial mutation rate that then fell in a study that combined laser capture microdissections with whole-genome sequencing of samples from three individuals. A team led by the Korea Advanced Institute of Science and Technology's Young Seok Ju similarly found a high mutational rate during the early stages of development that then declined, using a capture-recapture approach.

The Stratton-led team estimated that the first two cell divisions had mutation rates of 2.4 per cell per generation, which then fell to 0.7 per cell per generation. This dip, they said, is likely due to the activation of the zygotic genome that increases the ability to repair DNA.

These early cells also contributed unequally to the development of subsequent lineages, though the degree of asymmetry varied from person to person. Ju and his colleagues reported, for instance, that for one individual in their analysis, 112 early lineages split at a ratio of 6.5:1, rather than the expected 1:1.

Stratton and his colleagues, meanwhile, reported that one individual in their study had a 69:31 contribution of the initial daughter cells to subsequent lineages, while another had a 93:7 ratio based on bulk brain samples, but an 81:19 ratio based on colon samples.

This, they said, indicates that the lineage commitment of cells is not fixed. Ju and his colleagues likewise said their finding suggested a stochasticity of clonal segregation in humans, unlike the deterministic embryogenesis observed in C. elegans.

These analyses also shed light on the development of somatic mutations later in life. KAIST's Ju and his colleagues, for instance, found most mutations are specific to certain clones, while in a separate study, the Sanger's Moore and her colleagues, who examined the mutational landscape of 29 cell types from three individuals through sequencing, found mutationrates varied by cell type and were very low in spermatogonia.

Ju and his colleagues also reported that normal tissues harbored known mutational signatures, including UV-mediated DNA damage and endogenous clock-like mutagenesis. Similarly, Moore and her colleagues noted known mutational signatures within normal tissues. They found, for instance, the aging-related SBS1 and SBS5 mutational signatures to be the most common signatures across all cell types, while other signatures were more prominent in certain cell types but not others. The SBS88 signature, which is due to a strain of E. coli, for example, was present among colorectal and appendiceal crypts.

Chen Wu, an investigator at the Chinese Academy of Medical Sciences, and her colleagues also found the aging-related SBS1 and SBS5 mutational signatures to be common among normal tissues, based on their sequencing analysis of microbiopsies from five individuals. Other tissues, like the liver and lung, also harbored other mutational signature like SBS4, which is associated with tobacco smoking.

Some of the mutations present in normal somatic tissues are typically associated with cancer, Wu and her colleagues added. They found mutations in 32 cancer driver genes were widespread among their normal tissue samples, though varied by organ. For instance, driver mutations were present in 6.5 percent of pancreas parenchyma samples and in 73.8 percent of esophageal samples.

Additionally, many normal tissue samples harbored as many as three cancer driver mutations. This, Harvard Medical School's Kamila Naxerova noted in a related commentary in Nature, begins to blur the line between what is normal and what is cancer. "Indeed, if cells with three driver mutations can easily be found in a small tissue sample, cells with four or five drivers probably exist in that tissue as well without necessarily giving rise to cancer," she wrote. "These new insights invite us to reconsider how we genetically define cancer."

Overall, she added that "the four studies provide an impressive demonstration of the power of modern genetics to decode the cellular dynamics that unfold in our bodies over time."

See the article here:
Genetic Analyses Trace How Mutations Accumulate in Cells of the Human Body Over Time - GenomeWeb

Department of Physiology and Biophysics Seminar – umc.edu

Main Content

When: Wednesday, September 01, 2021, from 12:00 p.m. to 1:00 p.m.Location: WebEx

Contact Info: Courtney Graham at chortongraham@umc.edu or 601-984-1820Related Link: Click here to view event flyer

Dr. Jennifer Sones, Associate Professor of Theriogenology in the Department of Physiology/ School of Medicine, will give the virtual Department of Physiology and Biophysics Seminar, Metabolic Basis of Disease in BPH/5 Mice, at noon on Wednesday, Sept. 1, online via WebEx.

Originally posted here:
Department of Physiology and Biophysics Seminar - umc.edu

Awards and Honors Across Weill Cornell Medicine August 27, 2021 – Weill Cornell Medicine Newsroom

Dr. Dolores Lamb, who was recruited as assistant professor of molecular biology in urology, has been elected Eastern Regional Administrative Secretary at the American Association of Bioanalysts (AAB) as a member of the AAB Membership Review Committee. Dr. Lambs term began in June 2021.

Dr. Christopher Mason, co-director of theWorldQuant Initiative for Quantitative Predictionand a professor of physiology and biophysics, has been selected to serve on the National Academy of Sciences (NAS) Committee to develop the next 10 years of NASA and space medicine priorities.

Continue reading here:
Awards and Honors Across Weill Cornell Medicine August 27, 2021 - Weill Cornell Medicine Newsroom

New imaging, machine-learning methods speed effort to reduce crops’ need for water – University of Illinois News

CHAMPAIGN, Ill. Scientists have developed and deployed a series of new imaging and machine-learning tools to discover attributes that contribute to water-use efficiency in crop plants during photosynthesis and to reveal the genetic basis of variation in those traits.

The findings are described in a series of four research papers led by University of Illinois Urbana-Champaign graduate students Jiayang (Kevin) Xie and Parthiban Prakash, and postdoctoral researchers John Ferguson, Samuel Fernandes and Charles Pignon.

The goal is to breed or engineer crops that are better at conserving water without sacrificing yield, said Andrew Leakey, a professor of plant biology and of crop sciences at the University of Illinois Urbana-Champaign, who directed the research.

Drought stress limits agricultural production more than anything else, Leakey said. And scientists are working to find ways to minimize water loss from plant leaves without decreasing the amount of carbon dioxide the leaves take in.

Plants breathe in carbon dioxide through tiny pores in their leaves called stomata. That carbon dioxide drives photosynthesis and contributes to plant growth. But the stomata also allow moisture to escape in the form of water vapor.

A new approach to analyzing the epidermis layer of plant leaves revealed that the size and shape of the stomata (lighter green pores) in corn leaves strongly influence the crops water-use efficiency.

Micrograph by Jiayang (Kevin) Xie

Edit embedded media in the Files Tab and re-insert as needed.

The amount of water vapor and carbon dioxide exchanged between the leaf and atmosphere depends on the number of stomata, their size and how quickly they open or close in response to environmental signals, Leakey said. If rainfall is low or the air is too hot and dry, there can be insufficient water to meet demand, leading to reduced photosynthesis, productivity and survival.

To better understand this process in plants like corn, sorghum and grasses of the genus Setaria, the team analyzed how the stomata on their leaves influenced plants water-use efficiency.

We investigated the number, size and speed of closing movements of stomata in these closely related species, Leakey said. This is very challenging because the traditional methods for measuring these traits are very slow and laborious.

For example, determining stomatal density previously involved manually counting the pores under a microscope. The slowness of this method means scientists are unable to analyze large datasets, Leakey said.

There are a lot of features of the leaf epidermis that normally dont get measured because it takes too much time, he said. Or, if they get measured, its in really small experiments. And you cant discover the genetic basis for a trait with a really small experiment.

To speed the work, Xie took a machine-learning tool originally developed to help self-driving cars navigate complex environments and converted it into an application that could quickly identify, count and measure thousands of cells and cell features in each leaf sample.

Jiayang (Kevin) Xie converted a machine-learning tool originally designed to help self-driving cars navigate complex environments into an application that can quickly analyze features on the surface of plant leaves.

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

To do this manually, it would take you several weeks of labor just to count the stomata on a seasons worth of leaf samples, Leakey said. And it would take you months more to manually measure the sizes of the stomata or the sizes of any of the other cells.

The team used sophisticated statistical approaches to identify regions of the genome and lists of genes that likely control variation in the patterning of stomata on the leaf surface. They also used thermal cameras in field and laboratory experiments to quickly assess the temperature of leaves as a proxy for how much water loss was cooling the leaves.

This revealed key links between changes in microscopic anatomy and the physiological or functional performance of the plants, Leakey said.

By comparing leaf characteristics with the plants water-use efficiency in field experiments, the researchers found that the size and shape of the stomata in corn appeared to be more important than had previously been recognized, Leakey said.

Along with the identification of genes that likely contribute to those features, the discovery will inform future efforts to breed or genetically engineer crop plants that use water more efficiently, the researchers said.

The new approach provides an unprecedented view of the structure and function of the outermost layer of plant leaves, Xie said.

There are so many things we dont know about the characteristics of the epidermis, and this machine-learning algorithm is giving us a much more comprehensive picture, he said. We can extract a lot more potential data on traits from the images weve taken. This is something people could not have done before.

Leakey is an affiliate of the Carl R. Woese Institute for Genomic Biology at the U. of I. He and his colleagues report their findings in a study published in The Journal of Experimental Botany and in three papers in the journal Plant Physiology (see below).

The National Science Foundation Plant Genome Research Program, the Advanced Research Projects Agency-Energy, the Department of Energy Biosystems Design Program, the Foundation for Food and Agriculture Research Graduate Student Fellows Program, The Agriculture and Food Research Initiative from the U.S. Department of Agriculture National Institute of Food and Agriculture, and the U. of I. Center for Digital Agriculture supported this research.

Read more here:
New imaging, machine-learning methods speed effort to reduce crops' need for water - University of Illinois News

Neurological manifestations of COVID-19 in patients: from path physiology to therapy – DocWire News

This article was originally published here

Neurol Sci. 2021 Aug 21. doi: 10.1007/s10072-021-05505-7. Online ahead of print.

ABSTRACT

Coronavirus is a family of ARN positive single-stranded belonging to the family of Coronaviridae. There are several families of coronavirus that transmit more or less serious diseases. However, the so-called coronavirus-19 (SARS-CoV2) is the one that is currently causing most of the problems; in fact, biological dysfunctions that this virus causes provoke damage in various organs, from the lung to the heart, the kidney, the circulatory system, and even the brain. The neurological manifestations caused by viral infection, as well as the hypercoagulopathy and systemic inflammation, have been reported in several studies. In this review, we update the neurological mechanisms by which coronavirus-19 causes neurological manifestation in patients such as encephalomyelitis, Guillain-Barr syndrome, lacunars infarcts, neuropsychiatry disorders such as anxiety and depression, and vascular alterations. This review explains (a) the possible pathways by which coronavirus-19 can induce the different neurological manifestations, (b) the strategies used by the virus to cross the barrier system, (c) how the immune system responds to the infection, and (d) the treatment than can be administered to the COVID-19 patients.

PMID:34417704 | DOI:10.1007/s10072-021-05505-7

Read more from the original source:
Neurological manifestations of COVID-19 in patients: from path physiology to therapy - DocWire News

Inside the Pandemic – Crikey

Lets find our bearings in this ongoing COVID-19 pandemic.

Crikeys Janine Perrett and Amber Schultz, will be joined by one of Australias leading authorities on infection and immunity. Professor Peter Doherty shared the 1996 Nobel Prize in Medicine or Physiology for discovering the nature of cellular immune defence, and is the author of a new book entitled An insiders plague year.

Peter and his colleagues at the Doherty Institute have been at the forefront of the research and study of this highly infectious coronavirus. They are currently working with the federal government in assisting with official modelling to fill in those missing numbers from the four-stage plan.

He will be sharing insights into his new book and the role that science now plays in working with government to create effective health guidelines and policies.

What would you like to ask Peter about COVID-19, the pandemic, Australias response, and the way forward? The two most thoughtful questions will win a copy of the book at the end of the webinar.

Read this article:
Inside the Pandemic - Crikey

VOX POPULI: If it wasn’t for Takuo Aoyagi, life today would be different | The Asahi Shimbun: Breaking News, Japan News and Analysis – Asahi Shimbun

Apulse oximeter resembles an oversized plastic clothes pin at first glance.

Brought into the limelight by the novel coronavirus pandemic, the device is clipped onto the tip of a patient's index finger to instantly display the oxygen saturation of the blood.

I learned only recently that research by Japanese engineer Takuo Aoyagi led to the invention of the modern pulse oximeter.

Born in Niigata in 1936, Aoyagi aspired to be an inventor and studied engineering at university. After a stint at Shimadzu Corp., he joined Nihon Kohden Corp. in 1971, a leading manufacturer of medical electronics equipment, where he was told by his superior to "develop something unique."

A conversation with an anesthesiologist inspired Aoyagi to devote his research to the development of an easy-to-use device for determining the oxygen level in arterial blood.

Since oximeters back then could not read oxygen levels without drawing a blood sample, health care providers had to make a guess based on the complexion of individual patients.

Aoyagi focused on the pulse and succeeded in isolating signals from arterial blood, which made continuous monitoring possible.

That was a veritable coup. But it took a while before his invention was fully appreciated by the medical community.

The usefulness of his device was fully recognized only in the 1980s, when medical crises caused by oxygen deficiency under anesthesia made news headlines in the United States. This resulted in a number of companies rushing to commercialize pulse oximeters, which came to be marketed globally and saved countless lives.

Aoyagi late in his life was still working to improve his device.

When he died in April last year at the age of 84, a U.S. daily ran a lengthy obituary.

Naoki Kobayashi, 62, a special researcher at Nihon Kohden, recalled, "He was a dyed-in-the-wool engineer who wanted to make useful things rather than author academic papers."

A mourning Yale emeritus professor revealed that he had personally recommended Aoyagi for the 2013 Nobel Prize in Physiology or Medicine.

With more than 100,000 COVID-19 patients around the nation today forced to "help themselves" by recuperating at home, the pulse oximeter has become something of a national lifeline.

It is an invention that definitely deserves greater re-evaluation in Japan.

--The Asahi Shimbun, Aug. 28

* * *

Vox Populi, Vox Dei is a popular daily column that takes up a wide range of topics, including culture, arts and social trends and developments. Written by veteran Asahi Shimbun writers, the column provides useful perspectives on and insights into contemporary Japan and its culture.

Originally posted here:
VOX POPULI: If it wasn't for Takuo Aoyagi, life today would be different | The Asahi Shimbun: Breaking News, Japan News and Analysis - Asahi Shimbun

Solution to controlling excessive ripening and senescence of fruits – FreshPlaza.com

Once again for this campaign, pome fruit producers can count on Hold Plus technology to reduce the acceleration of the senescence and ripening processes for apples and pears. And as a novelty this year, Stoller Europe guarantees the use of the solution in Organic Agriculture.

Hold Plus, a Stoller Europe technologyToday, farmers are affected by increasingly unpredictable and significant climate risks that create some economic uncertainties, explains Elodie Brans of Stoller Europe. In this difficult context, Stoller brings a new solution through efficient technology to the various problems that can occur at the different growth stages of pome fruits.

In order to put fruit of quality on the market, Stoller has set up solutions to help crops grow under stress. These solutions are perfectly adapted to fruit orchards, which cover nearly 40,000 hectares in France. However, it is undeniable that fruit productions suffer from climate and technological hazards, which leads to a physiological decline in some regions.

Hold Plus is here to reduce the level of ethylene synthesis and the appearance of accelerated signs of ripening. In this way, the ripening and senescence stages of plant tissue occur at a slower pace. By acting on the enzymes responsible for ethylene biosynthesis, Hold Plus reduces their activity and the final production of ethylene. The solution helps to group ripening without any loss in production or quality, by maintaining the optimal organoleptic characteristics of the fruit before and after harvest.

Grouping ripening without any loss in production or qualityYears of research and many trials have shown that applying Hold Plus on the leaves of the apple tree reduces fruit drop after harvest as well as ethylene emission. Additionally, our great experience with fruit crops has demonstrated that the fruit continues to grow, at a slower pace. Therefore, Hold Plus is a particularly efficient solution to control ripening speed and guarantee a certain quality.

The technology was developed to reduce the fruits emission of ethylene and it gives physiological control over the ripening process of the fruits.

Monitoring fruit ripening at harvest time with the starch test. Foliar application of Hold Plus reduces the ripening speed of the fruits, allowing for good preservation and quality growth.

Improving fruit preservationGiven the important place of the apple on the French market, the Stoller technology is based on improving the preservation quality during the storage period. Harvesting the apples at the optimal ripening stage reduces the possibility of losses during the marketing phase.

Ensuring the quality of the fruit after harvest is a problem common to all apple producers. Hold Plus guarantees the optimal ripening of the fruits while allowing them to maintain a high quality during the entire harvest and the storage period. This is made possible by the synergies established with the active ingredient 1-MCP during storage. Additionally, trials conducted at the station show that foliar applications of Hold Plus on the apple tree help improve the firmness by +0.5 kg/cm2.

We offer this unique solution to help producers improve the quality of their fruit and minimize losses. This is part of the storing process strategy as it increases the length of preservation of the fruit. Obtaining the best state of the fruit is one of the Stoller goals. The efficiency of our solutions, validated by the various trials, helps farmers offer the best product to the most demanding customers.

The fruit sector in France can continue to offer well-preserved nutritional products of quality, while taking into account the requirements of a sustainable diet. Growing can then take place more intelligently and more rationally, so that higher productivity can be reached with the intensive use of inputs. It therefore meets the requirements of the Farm to Fork strategy and of organic and competitive farming, while meeting the challenges of climate change.

Stoller EuropeStoller Europe is a branch of the American multinational Stoller Group. It serves the agricultural markets of Europe, North Africa and Russia. Our team is composed of highly qualified professionals who combine deep knowledge of plant physiology with an understanding of local crops and their specific challenges.

For more information:Elodie BransStoller EuropePhone: +34 965 11 05 22https://stollereurope.com/fr

Visit link:
Solution to controlling excessive ripening and senescence of fruits - FreshPlaza.com